Li, D K <br/><br/>
Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis.  [electronic resource] 

 -  Annals of neurology  Aug 1999 
 - 197-206 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Standard No.: </label>10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis--pathology<br/>Prognosis<br/>Recurrence